Skip to content
ppharmaranks
Menu

serpanray

Serpanray (Reserpine) is a medication used to treat Hypertension, Schizophrenia, Dyskinesias.

Reserpine · by Panray

Available as a generic: Reserpine

Not yet rated· sourced from the FDA label
Rated against independent regulatory sources·Last updated June 7, 2026·How we rate
Verified againstopenFDANIH DailyMedRxClass
Compare online visit prices →We may earn a commission · never affects ratings

Key facts

Active ingredient
Reserpine
Form
Tablet
Strength
Reserpine 0.1MG · Reserpine 0.25MG · Reserpine 1MG
Type
Prescription (Rx)
Brand or generic
Brand-name
May treat
hypertension, schizophrenia, dyskinesias
Manufacturer
Panray
FDA application
NDA009391
Availability
Discontinued (per FDA)

May treat (source: NIH RxClass)

Dosage forms

Tablet

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

What does Serpanray treat?
Serpanray (Reserpine) may be used to treat hypertension, schizophrenia, dyskinesias, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
Is there a coupon or discount for Serpanray?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Serpanray. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Serpanray?
Serpanray is marketed by Panray. You can see Panray's full profile, rating, and other products on pharmaranks.
Is Serpanray a brand-name or generic drug?
Serpanray is a brand-name product with the active ingredient Reserpine. Lower-cost generic equivalents containing Reserpine are available — ask your pharmacist.
Is Serpanray available over the counter?
No. Serpanray is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Serpanray come in?
Serpanray is currently marketed as tablet, per the FDA's National Drug Code Directory.
Is Serpanray FDA-registered?
Serpanray is on record with the U.S. FDA under application number NDA009391. You can verify this on its official FDA label.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

What people report to the FDA about RESERPINE

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 235 reports naming RESERPINE — the active ingredient in Serpanray, and the FDA flagged 84% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • gastrointestinal haemorrhage15 reports
  • hypoglycaemia15 reports
  • shock15 reports
  • dyspnoea14 reports
  • dizziness13 reports
  • multiple organ dysfunction syndrome13 reports
  • nausea12 reports
  • fatigue11 reports

Read these as a signal, not a rate. A report does not mean RESERPINE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 26, 2026.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Serpanray head-to-head

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.